Next Article in Journal
Guidance Level for Brevetoxins in French Shellfish
Next Article in Special Issue
Marine Bromophenol Bis(2,3,6-Tribromo-4,5-Dihydroxybenzyl)ether Inhibits Angiogenesis in Human Umbilical Vein Endothelial Cells and Reduces Vasculogenic Mimicry in Human Lung Cancer A549 Cells
Previous Article in Journal
Synthesis of Marine Natural Products and Molecules Inspired by Marine Substances II
Previous Article in Special Issue
Synthesis and Cytotoxicity Evaluation of Spirocyclic Bromotyrosine Clavatadine C Analogs
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Oxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E

by
Tarik A. Mohamed
1,
Abdelsamed I. Elshamy
2,
Asmaa M. Abdel-Tawab
3,
Mona M. AbdelMohsen
1,
Shinji Ohta
4,
Paul W. Pare
5,* and
Mohamed-Elamir F. Hegazy
1,6,*
1
Chemistry of Medicinal Plants Department, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt
2
Department of Natural Compounds Chemistry, National Research Centre, 33 El-Bohouth St., Dokki, Giza 12622, Egypt
3
Marine Biotechnology and Natural Products Laboratory, National Institute of Oceanography and Fisheries, Cairo 11516, Egypt
4
Graduate School of Integrated Sciences for Life, Hiroshima University, 1-7-1 Kagamiyama, Higashi-Hiroshima 739-8521, Japan
5
Department of Chemistry & Biochemistry, Texas Tech University, Lubbock, TX 79409, USA
6
Department of Pharmaceutical Biology, Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg University, Staudinger Weg 5, 55128 Mainz, Germany
*
Authors to whom correspondence should be addressed.
Mar. Drugs 2021, 19(9), 519; https://doi.org/10.3390/md19090519
Submission received: 21 August 2021 / Revised: 10 September 2021 / Accepted: 11 September 2021 / Published: 13 September 2021
(This article belongs to the Special Issue Marine Natural Products as Anticancer Agents 2.0)

Abstract

:
The soft coral genus Sarcophyton contains the enzymatic machinery to synthesize a multitude of cembrene-type diterpenes. Herein, highly oxygenated cembrenoids, sarcoconvolutum A–E (15) were purified and characterized from an ethyl acetate extract of the red sea soft coral, Sarcophyton convolutum. Compounds were assemblies according to spectroscopic methods including FTIR, 1D- and 2D-NMR as well as HRMS. Metabolite cytotoxicity was tested against lung adenocarcinoma, cervical cancer, and oral-cavity carcinoma (A549, HeLa and HSC-2, respectively). The most cytotoxic compound, (4) was observed to be active against cell lines A549 and HSC-2 with IC50 values of 49.70 and 53.17 μM, respectively.

1. Introduction

Natural products and structural analogues are key for drug discovery, especially for pharmacotherapies for cancers and infectious diseases [1,2,3,4,5]. Such biologically active metabolites are characterized by scaffold diversity and structural complexity. For example, within Sarcophyton soft coral, isolated metabolites include cembrenoids [2,6,7,8,9], diterpene dimers [10,11], sesquiterpenes [12,13], ceramides [14], steroids [15,16], and prostaglandins [17,18]. Cembrenoids in particular exhibit a significant number of sp3 carbon centers and oxygen atoms with no nitrogen or halogen atoms. Higher numbers of H-bond acceptors and donors confer hydrophilicity and ring structures provide significant molecular rigidity. Cembrenoids also exhibit promising biological activities including anticancer [6,7,8], anti-inflammatory [8], antifouling [19,20], ichthyotoxic [21], antifeedant [12], antiviral [22], and neuroprotective [23] properties.
In a pursuit of novel metabolites with biological activity, polyoxygenated cembrene-type diterpenoids (Figure 1) have been isolated from the Red Sea soft coral S. convolutum. Metabolite antiproliferative activity was assayed against a non-small-cell lung adenocarcinoma, a cervical cancer, and an oral-cavity squamous-cell carcinoma, A549, HeLa, and HSC-2, respectively.

2. Results and Discussion

Sarcoconvolutum A (1) was isolated as yellow oil with a positive optical rotation (+10.6) in a MeOH solvent. The HRCIMS molecular ion peak at m/z 367.2122 [M + H]+ was assigned predicting a molecular formula of C20H30O6 (calcd. 367.2121, [M + H]+) with six degrees of unsaturation suggesting a bicyclic skeleton. FTIR spectrum exhibited bands at 3465 cm−1 and 1765 cm−1 corresponding to hydroxyls and carbonyl groups. From 1H NMR spectrum (Table 1), two oxygenated protons at δH 3.26 br d (J = 10.8 Hz) and 5.53 d (J = 10.4 Hz), three olefinic protons at δH 4.84 br d (J = 10.4 Hz), 5.48 br d (J = 16.3 Hz), and 5.50 m, in addition to four methyls were at δH 1.28 s, 1.37 s, 1.83 s, and 1.87 s were characterized. Twenty carbon resonances were predicted from 13C NMR (Table 1) and categorized into 6 quaternary (including carbonyl at δC 175.3; three olefinics at δC 123.1, 143.9 and 162.3; alongside of two oxygenated carbons at δC 74.5 and 84.1), five methines (comprising two oxygenated carbons at δC 71.6 and 79.4; as well as three olefinic at δC 121.1, 127.8, and 134.8), five methylenes, four methyls (δC 8.8, 16.5, 20.3, and 24.2) depending upon DEPT and HSQC experiments. The above analyses of 1D NMR of 1 revealed the cembrene-based diterpenoid [6,7,24]. The 1D NMR of 1 was similar to 12-hydroperoxylsarcoph-10-ene isolated previously from S. glaucum [24]. Observed signal differences for the newly isolated compound included a down field shift of H-7 and C-7 by 0.73 and 12.1 ppm, respectively; a down field shift of 15.3 ppm for C-8; and a down field shift of 6 ppm for Me-19 consistent with the substitution of a hydroxyl group at C-7 instead of an epoxide ring coupling C-7 and C-8. The proposed structure was confirmed by 1H 1H COSY and HMBC spectral analysis. H-2 [δH 5.53 d (J = 10.4 Hz)]/C-4 (δC 143.9, J3), and 1H 1H COSY of H-2/H-3 [δH 4.84 br d (J = 10.4 Hz)] indicated the location of Δ3(4). The HMBC correlation of H3-18 (δH 1.87 s) and CH2-5 (δC 35.2, J3) followed by 1H 1H COSY correlations of H2-5 [δH 2.18 br d (J = 12.7 Hz)]/ H-6 (δH 1.77 br d (J = 13.4 Hz)], H-6/H-7 (δH 3.26 br d (J = 10.8 Hz) confirmed a hydroxyl group at C-7. HMBC correlation of H3-19 (δH 1.28 s)/C-7 (δC 71.6, J3), H3-19/C-8 (δC 74.5, J3), and H-7/C-8 (J2) established hydroxylation of the C-8 quaternary carbon. Subsequently, HMBC correlation of H3-19/CH2-9 (δC 42.9, J3), H3-20 (δH 1.37 s)/CH2-11 (δC 134.8, J3), in addition to 1H 1H COSY of H2-9 [δH 2.34 m]/H-10 (δH 5.50 m), H-10/H-11 [(δH 5.48 br d (J = 16.3 Hz)] established Δ10(11). The down field shift of C-12 by ca. 7 ppm [24] as well as the HMBC correlation of H-11/C-12 (δC 84.1, J3), H3-20/C-12 (J2), and H3-20/C-13 (δC 34.4 J3) indicated the presence of a hydroperoxide group at C-12. The C-1/C-2 included lactone ring was established via HMBC of H-2/C-16 (keto group, δC 175.3, J3), H-2/C-15 (δC 123.1, J3), H3-17 (δH 1.83 s)/C-16 (J3), H3-17/C-1 (δC 162.3, J3), and H3-17/C-15 (Figure 2).
The relative configuration of 1 is based on coupling constants and NOESY data (Figure 3). From the coupling constant of H-2 (10.4 Hz) along with the vicinal coupling of H-3 (10.4 Hz), the cis orientation and α configuration of H-2 was established [7,24,25]. Starting from this point, the NOESY correlations of H-2α [δH 5.53 d (J = 10.4 Hz)]/ H3-18 [δH 1.87 s], H3-18/ H-5α [δH 2.18 br d (J = 12.7 Hz)], H3-18/ H-6α [δH 1.77 br d (J = 13.4)], H-5α/ H-6α, and H-6α/ H-7 [δH 3.26 br d (J = 10.8 Hz)] established an α orientation for H-7. NOESY correlations of H-6β [δH 1.41 ddd (J = 13.7, 12.7, 10.9 Hz)]/ H3-19 (δH 1.28 s), H-9β (δH 2.34 m)/ H3-19, H-9β/ H-11 [δH 5.48 br d (J = 16.3 Hz)], H-11/ H-13β [δH 1.72 br t (J = 13.2 Hz)], H-13β/ H3-20 [δH 1.37 s], H-11/ H3-20 indicated β configurations for both Me-19 and Me-20. Based on the described spectral analysis, 1 was identified as 7β,8α-dihydroxy-12α-hydroperoxide-16-keto-cembra-1E,3E,10E-triene (sarcoconvolutum A).
Sarcoconvolutum B (2) was isolated as yellow oil with a positive optical rotation (+43.1) in MeOH. From the HRCIMS molecular ion peak at m/z 367.2122 [M + H]+, the molecular formula of C20H30O6 (calcd. 367.2121, [M + H]+) a bicylic skeleton with six degrees of unsaturation was predicted. The FTIR broad bands corresponding to hydroxyls and carbonyl groups were detected at 3462 cm−1 and 1768 cm−1. The 1H NMR spectrum (Table 1) displayed two oxygenated protons at δH 3.32 d (J = 10.9 Hz) and 5.45 d (J = 10.2 Hz), three olefinic protons at δH 4.88 d (J = 10.1 Hz), 5.50 d (J = 16.1 Hz), and 5.57 dt (J = 16.1, 7.2 Hz), along with four methyls were at δH 1.28 s, 1.42 s, 1.82 s, 1.85 s. From the observed twenty signals in the 13C NMR spectrum (Table 1), 6 quartenary (including carbonyl at δC 174.8; three olefinics at δC 123.5, 143.5 and 161.9; alongside of two oxygenated carbons at δC 74.5 and 84.0), 5 methenes (comprising two oxygenated carbons at δC 78.7 and 71.1, as well as three olefinic signals at δC 121.6, 126.9, 134.6), 5 methylenes, 4 methyls (δC 8.9, 16.1, 23.6, and 24.1) were identified based on DEPT and HSQC signals. A down field shift of δC 84.0 by ca. 7 ppm suggested the presence of a hydroperoxyl unit at C-12 [24] which was consistent with mass spectral data. A 13C NMR comparison of the two isolated compounds indicated a down field shift of Me-20 for 2. The 2D NMR comparisons showed otherwise similar 1H 1H COSY and HMBC signals (Figure 2). A 13C NMR down field shift of 3.3 ppm for Me-20 indicated the opposite stereochemistry at C-12.
Relative stereochemistry was determined based on coupling constants and NOESY data (Figure 3). The coupling constant of H-2 (10.2 Hz) in addition to the vicinal coupling of H-3 (10.1 Hz) suggested a cis orientation and α configuration of H-2 [7,24,25]. The NOESY correlations of H-2α [δH 5.45 d (J = 10.2 Hz)]/ H3-18 [δH 1.82 s], H-18/ H-5 [δH 2.37 td (J = 13.2t, 2.8 Hz)], H-18/ H-6 [δH 1.49 td (J = 13.7t, 3.6 Hz)], H-5α/ H-6, H-6/ H-7 [δH 3.32 br d (J = 10.9 Hz)], H-7/ H-19 [δH 1.28 s] and H-13β [δH 1.95 td (J = 13.1, 4.1 Hz)]/ H3-19 indicated a H-7α Me-19 and Me-20orientation. Based upon these spectral data, 2 was identified as 7β,8α-dihydroxy-12β-hydroperoxide-16-keto-cembra-1E,3E,10E-triene (sarcoconvolutum B).
Sarcoconvolutum C (3) was isolated as yellow oil with a positive optical rotation (+33.1, c 0.003, CH3OH). The molecular formula was deduced as C21H32O6 (calcd. 364.2250, [M-OH + H]+) based on a HREIMS molecular ion peak at m/z 364.2258 [M-OH + H]+ indicating a bicylic skeleton with six degrees of unsaturation. FTIR broad bands corresponded to hydroxyls and carbonyl groups were detected at 3457 cm−1 and 1761 cm−1. From 1H NMR spectrum (Table 1), two oxygenated protons at δH 3.27 br d (J = 10.9 Hz) and δH 5.49 d (J= 9.9 Hz), three olefinic protons at δH 4.86 br d (J = 9.9 Hz), δH 5.44 br d (J = 16.1 Hz) and δH 5.56 dt (J = 15.6, 8.1t Hz), four methyls as well as one methyl of methoxy group at δH 3.23 s were assigned. Based on the 13C NMR (Table 1), twenty-one carbon resonances were observed and were categorized by DEPT and HSQC analysis as 6 quaternary carbons (including carbonyl at δC 174.8; three olefinics at δC 123.3, 144.2 and 161.4; alongside of two oxygenated carbons at δC 78.3 and 84.4), 5 methines (comprising two oxygenated carbons at δC 78.3 and 71.9; as well as three olefinic at δC 121.2, 128.2, 134.0), 5 methylenes, 5 methyls (δC 9.0, 16.2, 18.2, 21.2, and 49.3). As with 1 and 2, down field shift at δC 84.4 ppm of ca. 7 ppm along with a mass shift of [M-H2O], suggested the addition of a hydroperoxy group [24]. The compound is similar to 1 and 2 except for a down field shift of δH 78.3 by 3.8 ppm associated with C-8 and a new methoxyl signal at δH 3.23 s and δC 49.3. HMBC correlations of a methyl proton at δH 3.23 and the C-12 at δH 78.3 confirm the localization of the methoxylation to C-12 (Figure 2). Thus, 3 was identified as 7-hydroxy-8-methoxy-12-hydroperoxide-16-keto-cembra-1E,3E,10E-triene.
The relative configuration of 3 was deduced via the coupling constants and NOESY analysis (Figure 3). The coupling constant of H-2 (9.9 Hz) and the vicinal coupling of H-3 (9.9 Hz) identified an α and cis orientation for H-2 [7,24,25]. The NOESY experiments exhibited the same configuration of 1 that elucidated the α orientation of H-7 and β and both methyls, Me-19 and Me-20. Based on these spectral observations, 3 was identified as 7β-hydroxy-8α-methoxy-12α-hydroperoxide-16-keto-cembra-1E,3E,10E-triene (sarcoconvolutum C).
Sarcoconvolutum D (4) was obtained as dark yellow oil with a positive optical rotation (+37.2, c 0.003, CH3OH). The HREIMS molecular ion peak at m/z 348.1939 [M]+ that predicted a molecular formula of C20H28O5 (calcd. 348.1937, [M]+) with a bicylic skeleton and seven degrees of unsaturation. The corresponding FTIR broad bands to hydroxyls and carbonyl groups at 3456 cm−1 and 1763 cm−1 were assigned. The 1H NMR (Table 1) revealed two oxygenated protons at δH 2.65 dd (J = 6.8, 3.6 Hz), and 5.45 d (J = 9.4 Hz), three olefineic protons at δH 5.00 d (J = 9.4 Hz), 5.42 m, and 5.47 m, in addition to four methyls at δH 1.31 s, 1.41 s, 1.86 s, and 1.87 s. From 13C NMR, twenty carbon resonances were characterized and categorized to six quartenary (consisting of carbonyl at δC 174.8; three olefinics at δC 123.6, 144.4, and 161.7; and two oxygenated carbons at δC 60.0 and 84.6, five methenes (comprising two oxygenated carbons at δC 57.0, and 78.8; and two olefinic carbon (at δC 125.8 and 135.5), five methylenes, four methyls based on DEPT-135 and HSQC analysis. The compound is very similar to 1 except for an up-field shift of δH 2.65 dd (J = 6.8, 3.6 Hz) by 0.67 ppm and an up-field shift of δC 57.0 by 14.6 ppm both associated with C-7 and an up-field shift of δC 60 by 14.5 ppm associated with C-8. These chemical shift changes were deduced to be a result of a C-7/C-8 epoxide ring that was consistent with a molecular ion peak at m/z 348.1939 (C20H28O5). The localization of this group was derived via the HMBC correlations of Me-19 (δH 1.31 s)/C-7 (J3), Me-19/C-8 (J2), H-6 (δH 1.60 m)/C-7 (J2), and H-6/C-8 (J3) (Figure 2).
The relative stereochemistry was identified via coupling constants [7,24,25] and NOESY analysis (Figure 3). Compound 4 exhibited almost same NOESY correlations as 1 except the correlations of Me-19/H-7, and H-6β/H-7 that elucidated the β orientation of H-7. These data confirmed 4 as 12α-hydroperoxide-16-keto-cembra-1E,3E,10E-triene-7α, 8α-epoxide (sarcoconvolutum D).
Sarcoconvolutum E (5) was obtained as yellow oil exhibiting a positive optical rotation (+61.7, c 0.003, CH3OH). The mass spectroscopy exhibited a HREIMS molecular ion peak at m/z 367.2130 [M + H]+ that was identified as C20H30O6 (calcd. 367.2042, [M + H]+) with a bicylic skeleton and six degrees of unsaturation. The FTIR broad bands corresponding to hydroxyls and carbonyl groups were detected at 3464 cm−1 and 1759 cm−1. 1H NMR (Table 1) displayed three oxygenated protons at δH 3.45 br d (J = 10.5 Hz), 4.43 dd (J = 9.0, 5.0 Hz), and 5.47 d (J = 10.1 Hz), one olefineic proton at δH 4.92 br d (J = 10.1 Hz), one exomethylene proton at δH 5.07 s, and 5.13 s, and three methyles at δH 1.26 s, 1.86 s (6H). The 13C NMR showed twenty carbon resonances. Six quaternary (including carbonyl at δC 174.9; four olefinics at δC 124.3, 145.9, 146.0 and 161.8; and one oxygenated carbon at δC 73.9), four methenes (comprising two oxygenated carbons at δC 70.0 and 89.3; and one olefinic carbon (at δC 119.2), 7 methylenes (comprising exomethylene carbon at δC 113.4), three methyls (δC 8.9, 16.4, and 24.8) that were characterized via DEPT-135 and HSQC experiments. NMR spectral data of 5 were similar to 1 and 2 except for the following signals: (i) a down-field shift of δC 75.0, by ca. 3.5 ppm associated with C-7; (ii) an downfield shift of δH 3.45 brd (J = 10.5 Hz) by 0.2 ppm associated with H-7; and (iii) an up-field shift of δH 4.43 dd (J = 9.0, 5.0 Hz) by 1 ppm and a shift of ca. 45 ppm of δC 134.0 to 89.0 associated with C-11 indicating the oxygenation of this carbon; (iv) the appearance of δH 1.32 (m, 1.57) associated with H-10 and C-10 (at δC 25.0) indicating a disappearance of Δ10(11); and (v) the presence of δC 146.0 associated with C-12 and signals δH 5.07 s, 5.13 s and δC 113.4 associated with an exomethylene carbon at C-20 indicating the presence of Δ12(20). These new functional group assignments based on spectral data were consistent with 2D HMBC spectral signals including H3-19 [δH 1.26 s]/C-7 [δC 75.0, J3], H3-19/C-7 [δC 73.9, J2] confirmed the hydroxylation of both C-7 and C-8. The HMBC correlations of H2-20 [at δH 5.07 s, 5.13 s]/C-12 [at δC 146.0, J2], H2-20/C-11 [at δC 89.0, J3], and H2-20/C-13 [at δC 27.8, J3], H-11 [at δH 4.43 dd (J = 9.0, 5.0 Hz)]/C-12 [J2], H-11/C-13 [J3] confirmed the Δ12(20) and the oxygenation of C-11 (Figure 2). Consistent with the mass spectral data and the observed up-field shift of C-11, the oxygenation of C-11 was identified as a hydroperoxide group.
The relative stereochemistry assignment was based the coupling constant of H-2 (10.1 Hz) and the vicinal coupling of H-3 (10.1 Hz) the indicated a α and cis orientation of H-2 [7,24,25]. NOESY correlations (Figure 3) of H-2α [δH 5.47 d (J = 10.1 Hz)]/ H3-18 [δH 1.86 s], H-3α [δH 4.92 br d (J = 10.1 Hz)]/ H-5α [δH 2.35 dt (J = 13.0, 7.6t Hz)], and H-5α/ H-6 [δH 1.75 m], H3-18/ H-6, H-5/ H-7 [δH 3.45 br d (J= 10.5 Hz)], H-6/ H-7, H-7/ H3-19 [δH 1.26 s], H3-19β/ H-9β [δH 1.51 m], H-9β/ H-11 [δH 4.43 dd (J = 9.0, 5.0 Hz)], H-13β [δH 2.25 m]/ H-identified a β orientation for H-7, H-11 and Me-19. Therefore, 5 was assigned as 7α,8α-dihydroxy-11α-hydroperoxide-16-keto-cembra-1E,3E,12(20)-triene (sarcoconvolutum E). 1D, 2D-NMR, HRMS and FTIR for all isolated secondary metabolites (1–5) were deposited in the supplementary files (see Figures S1–S50).
The initial screening of 15 (Figure 4) for cytotoxic activity was performed using three cancer cell lines (A549, HeLa and HSC-2) with concentrations of 100, 10 and 1 μM (Figure 4A). Compound 4 showed cytotoxic activity against cell lines A549 (Figure 4B) and HSC-2 (Figure 4C). The dose-dependent toxicity with concentrations range (0.001–100 μg/mL) was examined against A549 and HSC-2 cell lines (Figure 4). Compound 4 showed IC50 values of 49.70 and 53.17 μM against A549 and HSC-2 cells, respectively (Table 2, Figure 4A,B).

3. Materials and Methods

3.1. General Experimental Procedures

A JASCO P-2300 polarimeter (Tokyo, Japan) and shimazu FTIR-8400S instrument (Columbia, MD 21046, USA) was operated for optical rotation and IR spectra, respectively. Then, 1D and 2D NMR spectra were recorded on a Bruker 600 or 500 Hz NMR spectrometer (MA, USA). HR-MS spectra were obtained on a JEOL JMS-700 instrument (Tokyo, Japan). For Chromatography: column chromatography (CC) [silica gel 60 (Merck, 230–400 mesh, Merck, Darmstadt, Germany)]; TLC analysis: [precoated silica gel plates (Merck, Kieselgel 60 F254, 0.25 mm, Merck, Darmstadt, Germany]. High-performance liquid chromatography (HPLC) equipped with a Jasco PU-980 pump, a Jasco UV-970 intelligent UV/VIS detector at 210 nm and a semi preparative reversed-phase column (Cosmosil C18 column 250 × 10 mm, 5 μm).

3.2. Coral Material

The animal soft coral Sarcophyton convolutum was collected from the Egyptian Red Sea (the coast of Hurghada) in March 2017 and was recognized by M Al-Hammady with a voucher specimen (08RS1071). It was deposited in the National Institute of Oceanography and Fisheries, marine biological station, Hurghada, Egypt.

3.3. Extraction and Separation

The frozen soft coral (2.5 kg, total wet weight) was chopped into small pieces and extracted with ethyl acetate at room temperature (3 L × 5 times). The collective extracts were concentrated in vacuo to a brown gum. The dried material (95 g) was subjected to a silica gel column (6 × 120 cm) eluting with n-hexane (2000 mL), followed by a gradient of n-hexane-EtOAc up to 100% EtOAc and EtOAc –MeOH up to 50% MeOH (3000 mL each of the solvent mixture). Fractions were collected (SC1-SC6) and monitored via TLC. Fraction (SC3; 1.4 g) was eluted step gradient with n-hexane-EtOAc over silica gel column afforded three main sub fractions (SC3A-C). Sub-fraction SC3A was re-purified by reversed-phase HPLC using MeOH/H2O (6.5:3.5), 3.5 mL/min, to afford 1 (6.1 mg, tR = 27 min), and 4 (11.6 mg, tR = 23 min). The sub-fraction SC3B was subjected to reversed-phase HPLC using MeOH/H2O (3:2), 3.5 mL/min, afforded 2 (10 mg, tR = 28 min). Fraction (SC4; 1.2 g) was further fractionated over silica gel column chromatography eluted by n-hexane/EtOAc step gradient afforded two main sub-fractions (SC4A and B). Sub-fraction SC4A was eluted with MeOH/H2O (1:1) over reversed-phase HPLC, 3 mL/min, to afford 3 (7.3 mg, tR = 31 min), and 5 (9.6 mg, tR = 32 min).

3.4. Spectral Data of Sarcoconvolutum A–E (1–5)

7,8-Dihydroxy-12-hydroxy-16-keto-cembra-1E,3E,10E-triene (Sarcoconvolutum A, 1): yellow oil; [α] D 25 +43.0 (c 0.03, CH3OH); FT-IR (KBr) νmax: 3465, 2961, 1765, 1435, and 987 cm−1; 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HRCIMS m/z 367.2122 (100, [M+H]+); (calcd. 367.2121, for C20H31O6).
7,8-Dihydroxy-12-hydroxy-16-keto-cembra-1E,3E,10E-triene (Sarcoconvolutum B, 2): yellow oil; [α] D 25 +10.5 (c 0.03, CH3OH); FT-IR (KBr) νmax: 3461, 2957, 1759, 1439, and 991 cm−1; 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HRCIMS m/z 367.2122 (100, [M+H]+); (calcd. 367.2122, for C20H31O6).
7β-Hydroxy-8α-methoxy-12α-hydroperoxide-16-keto-cembra-1E,3E,10E-triene (sarcoconvolutum C, 3): yellow oil; [α] D 25 +37.2 (c 0.03, CH3OH); FT-IR (KBr) νmax: 3456, 2951, 1763, 1446, and 993 cm−1; 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HRCIMS m/z 364.2258, [M-OH+H]+]; (calcd. 364.2250, [M-OH+H]+, for C21H32O6).
12α-Hydroperoxide-16-keto-cembra-1E,3E,10E-triene-7α,8α-epoxide (sarcoconvolutum D, 4): yellow oil; [α] D 25 +37.2 (c 0.03, CH3OH); FT-IR (KBr) νmax: 3456, 2958, 1763, 1442, and 996 cm−1; 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HREIMS m/z 348.1939 [M]+; (calcd. 348.1937, for C20H28O5).
7α,8α-Dihydroxy-11α-hydroperoxide-16-keto-cembra-1E,3E,12(20)-triene (sarcoconvolutum E, 5): yellow oil; [α] D 25 +10.5 +61.7 (c 0.03, CH3OH); FT-IR (KBr) νmax: 3464, 2955, 1759, 1433, and 997 cm−1; 1H and 13C NMR data (CDCl3, 500 Hz), see Table 1; HREIMS m/z 367.2130 (100, [M+H]+); (calcd. 367.2042, for C20H31O6).

3.5. Cell Culture and Treatment Conditions

Human cancer cell lines of non-small cell lung adenocarcinoma (A549), squamous cell carcinoma of the oral cavity (HSC-2), and human cervical cancer cell (HeLa). All cell lines were purchased from American Type Culture Collection (ATCC®) and were maintained as monolayer culture in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10% FBS, 4 mM l-glutamine, 100 U/mL penicillin, and 100 µg/mL streptomycin sulfate. Monolayers were passaged at 70–90% confluence using a trypsin-EDTA solution. All cell incubations were maintained in a humidified CO2 incubator with 5% CO2 at 37 °C. All materials and reagents for the cell cultures were purchased from Lonza (Verviers, Belgium).

3.6. Cytotoxicity Assay

A modified MTT (3-[4,5,[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide) assay was used for cytotoxicity investigation were performed using based on a previously published method [26]. A549, HeLa and HSC2 cells (5000–10,000 cells/well) were seeded onto 96-well plates and incubated for 24 h with 5% CO2 at 37 °C. The prepared tested compounds (15) were screened and the dose-dependent toxicity with concentrations range (0.001–100 μg/mL) were investigated according to our protocol [26]. Doxorubicin (2 mg/mL) was used as positive control.

3.7. Anti-Proliferation Quantitative Analysis

GraphPad Prism® v6.0 software (GraphPad Software Inc., San Diego, CA, USA) were used to calculate the concentration-response curve fit to the non-linear regression for IC50 values.

4. Conclusions

Five compounds, sarcoconvolutum A–E were isolated from an organic extract of Sarcophyton convolutum tissue. Chemical structures were elucidated based upon spectroscopic analyses. The cytotoxic activity of the isolated compounds was screened against three cancer cell lines (A549, HeLa and HSC2) and 4 was found to be the most active compound against cell lines A549 and HSC-2 with IC50 values of 49.70 and 53.17 μM, respectively.

Supplementary Materials

The following are available online https://www.mdpi.com/article/10.3390/md19090519/s1, Figures S1–S50: spectra for compounds 15.

Author Contributions

Conceptualization, T.A.M., A.I.E., P.W.P. and M.-E.F.H.; Data curation, T.A.M., A.I.E., A.M.A.-T. and M.-E.F.H.; Formal analysis, T.A.M., A.I.E., M.M.A., P.W.P. and S.O.; Investigation, T.A.M., A.I.E. and A.M.A.-T. Methodology, M.-E.F.H.; Project administration, T.A.M. and M.-E.F.H.; Resources, T.A.M., A.I.E., A.M.A.-T. and M.-E.F.H.; Software, T.A.M. and M.-E.F.H.; Supervision, M.-E.F.H.; Visualization, T.A.M. and M.-E.F.H.; Writing—original draft, A.I.E. and M.M.A.; Writing—review and editing, T.A.M., A.I.E., A.M.A.-T., M.M.A., S.O., P.W.P. and M.-E.F.H. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by National Research Centre, Giza, Egypt under the project title “Secondary metabolites from Egyptian Soft corals: Chemical and biological investigation against cancer cells” grant number 12060120/2019-2022.

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

The data presented in this study are available in Supplementary Material.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ahmed, A.A.; Hegazy, M.-E.F.; Hassan, N.M.; Wojcinska, M.; Karchesy, J.; Pare, P.W.; Mabry, T.J. Constituents of Chrysothamnus viscidiflorus. Phytochemistry 2006, 67, 1547–1553. [Google Scholar] [CrossRef]
  2. Hegazy, M.E.F.; Mohamed, T.A.; Alhammady, M.A.; Shaheen, A.M.; Reda, E.H.; Elshamy, A.I.; Aziz, M.; Paré, P.W. Molecular architecture and biomedical leads of terpenes from red sea marine invertebrates. Mar. Drugs 2015, 13, 3154–3181. [Google Scholar] [CrossRef] [PubMed]
  3. Khalifa, S.A.M.; Elias, N.; Farag, M.A.; Chen, L.; Saeed, A.; Hegazy, M.-E.F.; Moustafa, M.S.; El-Wahed, A.; Al-Mousawi, S.M.; Musharraf, S.G. Marine natural products: A source of novel anticancer drugs. Mar. Drugs 2019, 17, 491. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Nweze, J.A.; Mbaoji, F.N.; Li, Y.-M.; Yang, L.-Y.; Huang, S.-S.; Chigor, V.N.; Eze, E.A.; Pan, L.-X.; Zhang, T.; Yang, D.-F. Potentials of marine natural products against malaria, leishmaniasis, and trypanosomiasis parasites: A review of recent articles. Infect. Dis. Poverty 2021, 10, 1–19. [Google Scholar] [CrossRef]
  5. Hegazy, M.-E.F.; Mohamed, T.A.; Abdel-Latif, F.F.; Alsaid, M.S.; Shahat, A.A.; Pare, P.W. Trochelioid A and B, new cembranoid diterpenes from the Red Sea soft coral Sarcophyton trocheliophorum. Phytochem. Lett. 2013, 6, 383–386. [Google Scholar] [CrossRef]
  6. Hegazy, M.-E.F.; Elshamy, A.I.; Mohamed, T.A.; Hamed, A.R.; Ibrahim, M.A.A.; Ohta, S.; Paré, P.W. Cembrene diterpenoids with ether linkages from Sarcophyton ehrenbergi: An anti-proliferation and molecular-docking assessment. Mar. Drugs 2017, 15, 192. [Google Scholar] [CrossRef]
  7. Hegazy, M.-E.F.; Mohamed, T.A.; Elshamy, A.I.; Hamed, A.R.; Ibrahim, M.A.A.; Ohta, S.; Umeyama, A.; Paré, P.W.; Efferth, T. Sarcoehrenbergilides D–F: Cytotoxic cembrene diterpenoids from the soft coral Sarcophyton ehrenbergi. RSC Adv. 2019, 9, 27183–27189. [Google Scholar] [CrossRef] [Green Version]
  8. Lin, W.-Y.; Su, J.-H.; Lu, Y.; Wen, Z.-H.; Dai, C.-F.; Kuo, Y.-H.; Sheu, J.-H. Cytotoxic and anti-inflammatory cembranoids from the Dongsha Atoll soft coral Sarcophyton crassocaule. Bioorg. Med. Chem. 2010, 18, 1936–1941. [Google Scholar] [CrossRef] [PubMed]
  9. Liu, X.; Zhang, J.; Liu, Q.; Tang, G.; Wang, H.; Fan, C.; Yin, S. Bioactive cembranoids from the South China Sea soft coral Sarcophyton elegans. Molecules 2015, 20, 13324–13335. [Google Scholar] [CrossRef] [Green Version]
  10. Jia, R.; Guo, Y.-W.; Chen, P.; Yang, Y.-M.; Mollo, E.; Gavagnin, M.; Cimino, G. Biscembranoids and their probable biogenetic precursor from the Hainan soft coral Sarcophyton tortuosum. J. Nat. Prod. 2007, 70, 1158–1166. [Google Scholar] [CrossRef]
  11. Liang, L.F.; Guo, Y.W. Terpenes from the soft corals of the genus Sarcophyton: Chemistry and biological activities. Chem. Biodivers. 2013, 10, 2161–2196. [Google Scholar] [CrossRef] [PubMed]
  12. Yasumoto, M.; Mada, K.; Ooi, T.; Kusumi, T. New terpenoid components from the volatile oils of the soft corals Clavularia viridis and Sarcophyton acutangulum. J. Nat. Prod. 2000, 63, 1534–1536. [Google Scholar] [CrossRef]
  13. Anjaneyulu, A.S.R.; Rao, V.L.; Sastry, V.G.; Rao, D.V. Trocheliophorin: A novel rearranged sesquiterpenoid from the Indian Ocean soft coral Sarcophyton trocheliophorum. J. Asian Nat. Prod. Res. 2008, 10, 597–601. [Google Scholar] [CrossRef] [PubMed]
  14. Cheng, S.-Y.; Wen, Z.-H.; Chiou, S.-F.; Tsai, C.-W.; Wang, S.-K.; Hsu, C.-H.; Dai, C.-F.; Chiang, M.Y.; Wang, W.-H.; Duh, C.-Y. Ceramide and cerebrosides from the octocoral Sarcophyton ehrenbergi. J. Nat. Prod. 2009, 72, 465–468. [Google Scholar] [CrossRef]
  15. Anjaneyulu, A.S.R.; Krishna Murthy, M.V.R.; Gowri, P.M. Novel epoxy steroids from the Indian ocean soft coral Sarcophyton crassocaule. J. Nat. Prod. 2000, 63, 112–118. [Google Scholar] [CrossRef]
  16. Wang, Z.; Tang, H.; Wang, P.; Gong, W.; Xue, M.; Zhang, H.; Liu, T.; Liu, B.; Yi, Y.; Zhang, W. Bioactive polyoxygenated steroids from the South China sea soft coral, Sarcophyton sp. Mar. Drugs 2013, 11, 775–787. [Google Scholar] [CrossRef] [Green Version]
  17. Cheng, Z.-B.; Deng, Y.-L.; Fan, C.-Q.; Han, Q.-H.; Lin, S.-L.; Tang, G.-H.; Luo, H.-B.; Yin, S. Prostaglandin derivatives: Nonaromatic phosphodiesterase-4 inhibitors from the soft coral Sarcophyton ehrenbergi. J. Nat. Prod. 2014, 77, 1928–1936. [Google Scholar] [CrossRef]
  18. Sekhar, V.C.; Rao, C.B.; Ramana, H.; Kuwar, M.M.K.; Rao, D.V. New Prostaglandins from the soft coral Sarcophyton ehrenbergi marengeller of Andaman and Nicobar Islands of Indian ocean. Asian J. Chem. 2010, 22, 5353–5358. [Google Scholar]
  19. Li, Y.-X.; Wu, H.-X.; Xu, Y.; Shao, C.-L.; Wang, C.-Y.; Qian, P.-Y. Antifouling activity of secondary metabolites isolated from Chinese marine organisms. Mar. Biotechnol. 2013, 15, 552–558. [Google Scholar] [CrossRef]
  20. Sun, X.-P.; Wang, C.-Y.; Shao, C.-L.; Li, L.; Li, X.-B.; Chen, M.; Qian, P.-Y. Chemical constituents of the soft coral Sarcophyton infundibuliforme from the South China Sea. Nat. Prod. Commun. 2010, 5, 1171–1174. [Google Scholar] [CrossRef] [Green Version]
  21. Iwagawa, T.; Nakamura, S.; Masuda, T.; Okamura, H.; Nakatani, M.; Siro, M. Irregular cembranoids containing a 13-membered carbocyclic skeleton isolated from a soft coral, Sarcophyton species. Tetrahedron 1995, 51, 5291–5298. [Google Scholar] [CrossRef]
  22. Badria, F.A.; Guirguis, A.N.; El-Naggar, W.A. Antibacterial and antifungal agents from Egyptian marine organisms. Int. J. Pharmacogn. 1997, 35, 284–287. [Google Scholar] [CrossRef] [Green Version]
  23. Badria, F.A.; Guirguis, A.N.; Perovic, S.; Steffen, R.; Müller, W.E.G.; Schröder, H.C. Sarcophytolide: A new neuroprotective compound from the soft coral Sarcophyton glaucum. Toxicology 1998, 131, 133–143. [Google Scholar] [CrossRef]
  24. Hegazy, M.-E.F.; Eldeen, A.M.G.; Shahat, A.A.; Abdel-Latif, F.F.; Mohamed, T.A.; Whittlesey, B.R.; Paré, P.W. Bioactive hydroperoxyl cembranoids from the Red Sea soft coral Sarcophyton glaucum. Mar. Drugs 2012, 10, 209–222. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Elkhateeb, A.; El-Beih, A.A.; Gamal-Eldeen, A.M.; Alhammady, M.A.; Ohta, S.; Paré, P.W.; Hegazy, M.-E.F. New terpenes from the Egyptian soft coral Sarcophyton ehrenbergi. Mar. Drugs 2014, 12, 1977–1986. [Google Scholar] [CrossRef] [PubMed]
  26. Swapana, N.; Tominaga, T.; Elshamy, A.I.; Ibrahim, M.A.A.; Hegazy, M.-E.F.; Singh, C.B.; Suenaga, M.; Imagawa, H.; Noji, M.; Umeyama, A. Kaemgalangol A: Unusual seco-isopimarane diterpenoid from aromatic ginger Kaempferia galanga. Fitoterapia 2018, 129, 47–53. [Google Scholar] [CrossRef] [PubMed]
Figure 1. Sarcoconvolutum A–E (15) isolated from S. convolutum.
Figure 1. Sarcoconvolutum A–E (15) isolated from S. convolutum.
Marinedrugs 19 00519 g001
Figure 2. Key HMBC and 1H 1H COSY of sarcoconvolutum A–E (15).
Figure 2. Key HMBC and 1H 1H COSY of sarcoconvolutum A–E (15).
Marinedrugs 19 00519 g002
Figure 3. Significant NOESY of sarcoconvolutum A–E (15).
Figure 3. Significant NOESY of sarcoconvolutum A–E (15).
Marinedrugs 19 00519 g003
Figure 4. Cytotoxic activity: (A) Screening cytotoxic activity against A549, HeLa and HSC2 cell lines; (B) Dose-dependent toxicity with concentrations in a range from 0.001 to 100 μM for compounds 4 against A549; (C) Dose-dependent toxicity with concentrations in a range from 0.001 to 100 μM for compound 4 against HSC2.
Figure 4. Cytotoxic activity: (A) Screening cytotoxic activity against A549, HeLa and HSC2 cell lines; (B) Dose-dependent toxicity with concentrations in a range from 0.001 to 100 μM for compounds 4 against A549; (C) Dose-dependent toxicity with concentrations in a range from 0.001 to 100 μM for compound 4 against HSC2.
Marinedrugs 19 00519 g004
Table 1. 1H and 13C NMR (CDCl3, 500 Hz) of sarcoconvolutum A–E (15).
Table 1. 1H and 13C NMR (CDCl3, 500 Hz) of sarcoconvolutum A–E (15).
NoSarcoconvolutum A (1) Sarcoconvolutum B (2) Sarcoconvolutum C (3) Sarcoconvolutum D (4) Sarcoconvolutum E (5)
1H NMR (J Hz)13C1H NMR (J Hz)13C1H NMR (J Hz)13C1H NMR (J Hz)13C1H NMR (J Hz)13C
1----162.3----161.9----161.4----161.7----161.8
25.53 d (10.4)79.45.45 d (10.2)78.75.49 d (9.9)79.05.45 d (9.4) *78.85.47 d (10.1)80.2
34.84 br d (10.4)121.14.88 br d (10.1)121.64.86 br d (9.9)121.25.00 d (9.4)121.14.92 br d (10.1)119.2
4----143.9----143.5----144.2----144.4----145.9
2.18 br d (12.7)35.22.23 dt (13.2, 3.4t)35.32.18 dt (13.4, 3.4t)35.42.26 m *36.62.35 dt (13.0, 7.6t)37.9
2.40 t (11.3)2.37 td (13.2t, 2.8)2.37 td (13.4, 7.4)2.34 td (13.1t, 5.7)2.10 td (13.0t, 5.1)
1.77 br d (13.4)26.71.49 td (13.7t, 3.6)26.31.87 td (13.4t, 3.6)26.71.60 m24.11.75 m *30.5
1.51 ddd (13.7, 12.7, 10.9)1.83 m *1.44 td (15.3t, 4.3)1.82 m *1.25 m *
73.26 br d (10.8)71.63.32 br d (10.9)71.13.27 br d (10.9)71.92.65 dd (6.8, 3.6)57.03.45 br d (10.5)75.0
8----74.5----74.5----78.3----60.0----73.9
2.34 m *42.92.44 dd (13.7, 7.8) 43.42.34 m *37.22.41 dd (13.1, 5.7)39.01.57 m35.1
2.34 m *2.28 dd (13.4, 6.6)2.34 m *2.46 dd (13.3, 7.1)1.51 m
10α5.50 m127.85.57 dt (16.1, 7.2)126.95.56 dt (15.6, 8.1t)128.25.42 m *125.81.57 m25.2
10β1.32 m
115.48 br d (16.3)134.85.50 br d (16.1)134.65.44 br d (16.1)134.05.47 m *135.54.43 dd (9.0, 5.0)89.3
12----84.1----84.0----84.4----84.6----146.0
13α1.72 br t (13.2)34.41.49 td (13.7, 3.6)36.41.80 td (13.4t, 3.5) 35.11.58 m *36.02.02 br t (15.1) 27.8
13β1.68 td (13.2t, 5.6)1.95 td (13.1, 4.1)1.67 td (13.4t, 4.7)1.89 m *2.25 m
14α2.01 br t (13.2)22.72.06 br t (13.7)21.62.05 br t (13.4)22.72.07 br t22.02.13 m24.5
14β 2.43 br t (13.2) 2.62 td (13.7, 4.0) 2.40 td (13.7, 4.3)2.27 td * (13.2t, 5.5) 2.65 td (12.9, 4.9)
15----123.1----123.5----123.3----123.6----124.3
16----175.3----174.8----174.8----174.8----174.9
171.83 s8.81.85 s8.91.85 s9.01.86 s9.11.86 s8.9
181.87 s16.51.82 s16.11.83 s16.21.87 s15.81.86 s16.4
191.28 s24.21.28 s24.11.19 s18.21.31 s22.21.26 s24.8
201.37 s20.31.42 s23.61.41 s21.21.41 s18.85.07 s, 5.13 s113.4
OMe 3.23 s49.3
* overlapped.
Table 2. Cytotoxicity of 1-5 against cancer cell lines.
Table 2. Cytotoxicity of 1-5 against cancer cell lines.
Cell Lines(IC50, µM)
12345Doxorubicin
A549˃100˃100˃10049.70 ± 0.05˃1000.42 ± 0.3
HeLa˃100˃100˃10091.98 ± 0.15˃1001.35 ± 0.16
HSC2˃100˃100˃10053.17 ± 0.0391.39 ± 0.170.50 ± 2.6
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mohamed, T.A.; Elshamy, A.I.; Abdel-Tawab, A.M.; AbdelMohsen, M.M.; Ohta, S.; Pare, P.W.; Hegazy, M.-E.F. Oxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E. Mar. Drugs 2021, 19, 519. https://doi.org/10.3390/md19090519

AMA Style

Mohamed TA, Elshamy AI, Abdel-Tawab AM, AbdelMohsen MM, Ohta S, Pare PW, Hegazy M-EF. Oxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E. Marine Drugs. 2021; 19(9):519. https://doi.org/10.3390/md19090519

Chicago/Turabian Style

Mohamed, Tarik A., Abdelsamed I. Elshamy, Asmaa M. Abdel-Tawab, Mona M. AbdelMohsen, Shinji Ohta, Paul W. Pare, and Mohamed-Elamir F. Hegazy. 2021. "Oxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E" Marine Drugs 19, no. 9: 519. https://doi.org/10.3390/md19090519

APA Style

Mohamed, T. A., Elshamy, A. I., Abdel-Tawab, A. M., AbdelMohsen, M. M., Ohta, S., Pare, P. W., & Hegazy, M. -E. F. (2021). Oxygenated Cembrene Diterpenes from Sarcophyton convolutum: Cytotoxic Sarcoconvolutum A–E. Marine Drugs, 19(9), 519. https://doi.org/10.3390/md19090519

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop